Home > Insider Trading > Filing (0001209191-21-039704)

Filing Details

Accession Number:: 0001209191-21-039704
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-10 20:40:06
Reporting Period:: 2021-06-08

Accepted Time:: 2021-06-10 20:40:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
876378	Asensus Surgical Inc.	ASXC	Surgical & Medical Instruments & Apparatus (3841)	112962080

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1664960	J. C. Anthony Fernando	C/O Asensus Surgical, Inc. 1 Tw Alexander Drive, Suite 160 Durham NC 27703	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-06-08	550,000	$0.00	685,126	No	4	M	Direct
Common Stock	Disposition	2021-06-08	245,850	$3.37	439,276	No	4	F	Direct
Common Stock	Disposition	2021-06-08	2,112	$3.51	437,164	No	4	S	Direct
Common Stock	Acquisiton	2021-06-09	183,338	$0.82	620,502	No	4	M	Direct
Common Stock	Disposition	2021-06-09	183,338	$3.10	437,164	No	4	S	Direct
Common Stock	Disposition	2021-06-09	112,344	$3.10	324,820	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2021-06-08	550,000	$0.00	550,000	$0.00
Common Stock	Stock Option	Disposition	2021-06-09	183,338	$0.00	183,338	$0.82

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct
366,662	2021-06-08	2027-06-08	No	4	M	Direct

Footnotes

Lapse of forfeiture restrictions on one grant of restricted stock units ("RSUs") awarded on June 8, 2020.
This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares.
The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.50 to $3.525 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.0 to $3.19 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
Prior to the transactions reported on this Form 4 the reporting person owned 135,126 shares of the Company's common stock. Following the vesting and sale transactions reported on this Form 4, the reporting person increased his ownership of the Company's common stock by approximately 190,000 shares. The reporting person also holds stock options to acquire 575,269 shares of common stock, of which approximately 31% are vested, and restricted stock units representing an additional 278,206 shares of common stock subject to forfeiture restrictions.
Each RSU represents the right to receive one share of the Registrant's common stock.
Lapse of forfeiture restrictions on the 550,000 RSUs from this grant made on June 8, 2020.